ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Targeted Radionuclide Drug Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-14Z15017
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Targeted Radionuclide Drug Market Research Report 2023
BUY CHAPTERS

Global Targeted Radionuclide Drug Market Research Report 2025

Code: QYRE-Auto-14Z15017
Report
May 2025
Pages:105
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
POINT Biopharma
Telix
ITM
Bayer
Novartis
Lantheus
Curium Pharma
Fusion Pharmaceuticals
RadioMedix
Ionetix
Clarity Pharmaceuticals
RayzeBio
AmbioPharm
Bracco Imaging
Navidea
China Isotope & Radiation Corporation
Yantai Dongcheng
Grand Pharma
Hengrui Medicine
Yunnan Baiyao Group
SmartNuclide Biopharma
Sinotau
Hexin Pharmaceutical
Convergent Therapeutics

Targeted Radionuclide Drug Market

The global market for Targeted Radionuclide Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Targeted Radionuclide Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Targeted Radionuclide Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Targeted Radionuclide Drug in Tumors is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Targeted Radionuclide Drug include POINT Biopharma, Telix, ITM AG, Bayer AG, Novartis, Lantheus, Curium Pharma, Fusion Pharmaceuticals, RadioMedix, Inc., Convergent Therapeutics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Targeted Radionuclide Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted Radionuclide Drug.
The Targeted Radionuclide Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Targeted Radionuclide Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Targeted Radionuclide Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Targeted Radionuclide Drug Market Report

Report Metric Details
Report Name Targeted Radionuclide Drug Market
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company POINT Biopharma, Telix, ITM AG, Bayer AG, Novartis, Lantheus, Curium Pharma, Fusion Pharmaceuticals, RadioMedix, Inc., Convergent Therapeutics, IONETIX, Clarity Pharmaceuticals, RayzeBio, Inc, AmbioPharm, Bracco Imaging, Navidea, China Isotope & Radiation Corporation, Yantai Dongcheng, Grand Pharma, Hengrui Medicine, Yunnan Baiyao Group, SmartNuclide Biopharma, Sinotau, Hexin Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Targeted Radionuclide Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Targeted Radionuclide Drug Market report?

Ans: The main players in the Targeted Radionuclide Drug Market are POINT Biopharma, Telix, ITM AG, Bayer AG, Novartis, Lantheus, Curium Pharma, Fusion Pharmaceuticals, RadioMedix, Inc., Convergent Therapeutics, IONETIX, Clarity Pharmaceuticals, RayzeBio, Inc, AmbioPharm, Bracco Imaging, Navidea, China Isotope & Radiation Corporation, Yantai Dongcheng, Grand Pharma, Hengrui Medicine, Yunnan Baiyao Group, SmartNuclide Biopharma, Sinotau, Hexin Pharmaceutical

What are the Application segmentation covered in the Targeted Radionuclide Drug Market report?

Ans: The Applications covered in the Targeted Radionuclide Drug Market report are Tumors, Thyroid, Others

What are the Type segmentation covered in the Targeted Radionuclide Drug Market report?

Ans: The Types covered in the Targeted Radionuclide Drug Market report are Medicine, Inhibitor

Recommended Reports

Targeted Cancer Therapies

Radiopharmaceuticals & Isotopes

Radiation Oncology Devices

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted Radionuclide Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Medicine
1.2.3 Inhibitor
1.3 Market by Application
1.3.1 Global Targeted Radionuclide Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Tumors
1.3.3 Thyroid
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted Radionuclide Drug Market Perspective (2020-2031)
2.2 Global Targeted Radionuclide Drug Growth Trends by Region
2.2.1 Global Targeted Radionuclide Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Targeted Radionuclide Drug Historic Market Size by Region (2020-2025)
2.2.3 Targeted Radionuclide Drug Forecasted Market Size by Region (2026-2031)
2.3 Targeted Radionuclide Drug Market Dynamics
2.3.1 Targeted Radionuclide Drug Industry Trends
2.3.2 Targeted Radionuclide Drug Market Drivers
2.3.3 Targeted Radionuclide Drug Market Challenges
2.3.4 Targeted Radionuclide Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Targeted Radionuclide Drug Players by Revenue
3.1.1 Global Top Targeted Radionuclide Drug Players by Revenue (2020-2025)
3.1.2 Global Targeted Radionuclide Drug Revenue Market Share by Players (2020-2025)
3.2 Global Targeted Radionuclide Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Targeted Radionuclide Drug Revenue
3.4 Global Targeted Radionuclide Drug Market Concentration Ratio
3.4.1 Global Targeted Radionuclide Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Radionuclide Drug Revenue in 2024
3.5 Global Key Players of Targeted Radionuclide Drug Head office and Area Served
3.6 Global Key Players of Targeted Radionuclide Drug, Product and Application
3.7 Global Key Players of Targeted Radionuclide Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted Radionuclide Drug Breakdown Data by Type
4.1 Global Targeted Radionuclide Drug Historic Market Size by Type (2020-2025)
4.2 Global Targeted Radionuclide Drug Forecasted Market Size by Type (2026-2031)
5 Targeted Radionuclide Drug Breakdown Data by Application
5.1 Global Targeted Radionuclide Drug Historic Market Size by Application (2020-2025)
5.2 Global Targeted Radionuclide Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Targeted Radionuclide Drug Market Size (2020-2031)
6.2 North America Targeted Radionuclide Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Targeted Radionuclide Drug Market Size by Country (2020-2025)
6.4 North America Targeted Radionuclide Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Targeted Radionuclide Drug Market Size (2020-2031)
7.2 Europe Targeted Radionuclide Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Targeted Radionuclide Drug Market Size by Country (2020-2025)
7.4 Europe Targeted Radionuclide Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Targeted Radionuclide Drug Market Size (2020-2031)
8.2 Asia-Pacific Targeted Radionuclide Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Targeted Radionuclide Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Targeted Radionuclide Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Targeted Radionuclide Drug Market Size (2020-2031)
9.2 Latin America Targeted Radionuclide Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Targeted Radionuclide Drug Market Size by Country (2020-2025)
9.4 Latin America Targeted Radionuclide Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Targeted Radionuclide Drug Market Size (2020-2031)
10.2 Middle East & Africa Targeted Radionuclide Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Targeted Radionuclide Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Targeted Radionuclide Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 POINT Biopharma
11.1.1 POINT Biopharma Company Details
11.1.2 POINT Biopharma Business Overview
11.1.3 POINT Biopharma Targeted Radionuclide Drug Introduction
11.1.4 POINT Biopharma Revenue in Targeted Radionuclide Drug Business (2020-2025)
11.1.5 POINT Biopharma Recent Development
11.2 Telix
11.2.1 Telix Company Details
11.2.2 Telix Business Overview
11.2.3 Telix Targeted Radionuclide Drug Introduction
11.2.4 Telix Revenue in Targeted Radionuclide Drug Business (2020-2025)
11.2.5 Telix Recent Development
11.3 ITM AG
11.3.1 ITM AG Company Details
11.3.2 ITM AG Business Overview
11.3.3 ITM AG Targeted Radionuclide Drug Introduction
11.3.4 ITM AG Revenue in Targeted Radionuclide Drug Business (2020-2025)
11.3.5 ITM AG Recent Development
11.4 Bayer AG
11.4.1 Bayer AG Company Details
11.4.2 Bayer AG Business Overview
11.4.3 Bayer AG Targeted Radionuclide Drug Introduction
11.4.4 Bayer AG Revenue in Targeted Radionuclide Drug Business (2020-2025)
11.4.5 Bayer AG Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Targeted Radionuclide Drug Introduction
11.5.4 Novartis Revenue in Targeted Radionuclide Drug Business (2020-2025)
11.5.5 Novartis Recent Development
11.6 Lantheus
11.6.1 Lantheus Company Details
11.6.2 Lantheus Business Overview
11.6.3 Lantheus Targeted Radionuclide Drug Introduction
11.6.4 Lantheus Revenue in Targeted Radionuclide Drug Business (2020-2025)
11.6.5 Lantheus Recent Development
11.7 Curium Pharma
11.7.1 Curium Pharma Company Details
11.7.2 Curium Pharma Business Overview
11.7.3 Curium Pharma Targeted Radionuclide Drug Introduction
11.7.4 Curium Pharma Revenue in Targeted Radionuclide Drug Business (2020-2025)
11.7.5 Curium Pharma Recent Development
11.8 Fusion Pharmaceuticals
11.8.1 Fusion Pharmaceuticals Company Details
11.8.2 Fusion Pharmaceuticals Business Overview
11.8.3 Fusion Pharmaceuticals Targeted Radionuclide Drug Introduction
11.8.4 Fusion Pharmaceuticals Revenue in Targeted Radionuclide Drug Business (2020-2025)
11.8.5 Fusion Pharmaceuticals Recent Development
11.9 RadioMedix, Inc.
11.9.1 RadioMedix, Inc. Company Details
11.9.2 RadioMedix, Inc. Business Overview
11.9.3 RadioMedix, Inc. Targeted Radionuclide Drug Introduction
11.9.4 RadioMedix, Inc. Revenue in Targeted Radionuclide Drug Business (2020-2025)
11.9.5 RadioMedix, Inc. Recent Development
11.10 Convergent Therapeutics
11.10.1 Convergent Therapeutics Company Details
11.10.2 Convergent Therapeutics Business Overview
11.10.3 Convergent Therapeutics Targeted Radionuclide Drug Introduction
11.10.4 Convergent Therapeutics Revenue in Targeted Radionuclide Drug Business (2020-2025)
11.10.5 Convergent Therapeutics Recent Development
11.11 IONETIX
11.11.1 IONETIX Company Details
11.11.2 IONETIX Business Overview
11.11.3 IONETIX Targeted Radionuclide Drug Introduction
11.11.4 IONETIX Revenue in Targeted Radionuclide Drug Business (2020-2025)
11.11.5 IONETIX Recent Development
11.12 Clarity Pharmaceuticals
11.12.1 Clarity Pharmaceuticals Company Details
11.12.2 Clarity Pharmaceuticals Business Overview
11.12.3 Clarity Pharmaceuticals Targeted Radionuclide Drug Introduction
11.12.4 Clarity Pharmaceuticals Revenue in Targeted Radionuclide Drug Business (2020-2025)
11.12.5 Clarity Pharmaceuticals Recent Development
11.13 RayzeBio, Inc
11.13.1 RayzeBio, Inc Company Details
11.13.2 RayzeBio, Inc Business Overview
11.13.3 RayzeBio, Inc Targeted Radionuclide Drug Introduction
11.13.4 RayzeBio, Inc Revenue in Targeted Radionuclide Drug Business (2020-2025)
11.13.5 RayzeBio, Inc Recent Development
11.14 AmbioPharm
11.14.1 AmbioPharm Company Details
11.14.2 AmbioPharm Business Overview
11.14.3 AmbioPharm Targeted Radionuclide Drug Introduction
11.14.4 AmbioPharm Revenue in Targeted Radionuclide Drug Business (2020-2025)
11.14.5 AmbioPharm Recent Development
11.15 Bracco Imaging
11.15.1 Bracco Imaging Company Details
11.15.2 Bracco Imaging Business Overview
11.15.3 Bracco Imaging Targeted Radionuclide Drug Introduction
11.15.4 Bracco Imaging Revenue in Targeted Radionuclide Drug Business (2020-2025)
11.15.5 Bracco Imaging Recent Development
11.16 Navidea
11.16.1 Navidea Company Details
11.16.2 Navidea Business Overview
11.16.3 Navidea Targeted Radionuclide Drug Introduction
11.16.4 Navidea Revenue in Targeted Radionuclide Drug Business (2020-2025)
11.16.5 Navidea Recent Development
11.17 China Isotope & Radiation Corporation
11.17.1 China Isotope & Radiation Corporation Company Details
11.17.2 China Isotope & Radiation Corporation Business Overview
11.17.3 China Isotope & Radiation Corporation Targeted Radionuclide Drug Introduction
11.17.4 China Isotope & Radiation Corporation Revenue in Targeted Radionuclide Drug Business (2020-2025)
11.17.5 China Isotope & Radiation Corporation Recent Development
11.18 Yantai Dongcheng
11.18.1 Yantai Dongcheng Company Details
11.18.2 Yantai Dongcheng Business Overview
11.18.3 Yantai Dongcheng Targeted Radionuclide Drug Introduction
11.18.4 Yantai Dongcheng Revenue in Targeted Radionuclide Drug Business (2020-2025)
11.18.5 Yantai Dongcheng Recent Development
11.19 Grand Pharma
11.19.1 Grand Pharma Company Details
11.19.2 Grand Pharma Business Overview
11.19.3 Grand Pharma Targeted Radionuclide Drug Introduction
11.19.4 Grand Pharma Revenue in Targeted Radionuclide Drug Business (2020-2025)
11.19.5 Grand Pharma Recent Development
11.20 Hengrui Medicine
11.20.1 Hengrui Medicine Company Details
11.20.2 Hengrui Medicine Business Overview
11.20.3 Hengrui Medicine Targeted Radionuclide Drug Introduction
11.20.4 Hengrui Medicine Revenue in Targeted Radionuclide Drug Business (2020-2025)
11.20.5 Hengrui Medicine Recent Development
11.21 Yunnan Baiyao Group
11.21.1 Yunnan Baiyao Group Company Details
11.21.2 Yunnan Baiyao Group Business Overview
11.21.3 Yunnan Baiyao Group Targeted Radionuclide Drug Introduction
11.21.4 Yunnan Baiyao Group Revenue in Targeted Radionuclide Drug Business (2020-2025)
11.21.5 Yunnan Baiyao Group Recent Development
11.22 SmartNuclide Biopharma
11.22.1 SmartNuclide Biopharma Company Details
11.22.2 SmartNuclide Biopharma Business Overview
11.22.3 SmartNuclide Biopharma Targeted Radionuclide Drug Introduction
11.22.4 SmartNuclide Biopharma Revenue in Targeted Radionuclide Drug Business (2020-2025)
11.22.5 SmartNuclide Biopharma Recent Development
11.23 Sinotau
11.23.1 Sinotau Company Details
11.23.2 Sinotau Business Overview
11.23.3 Sinotau Targeted Radionuclide Drug Introduction
11.23.4 Sinotau Revenue in Targeted Radionuclide Drug Business (2020-2025)
11.23.5 Sinotau Recent Development
11.24 Hexin Pharmaceutical
11.24.1 Hexin Pharmaceutical Company Details
11.24.2 Hexin Pharmaceutical Business Overview
11.24.3 Hexin Pharmaceutical Targeted Radionuclide Drug Introduction
11.24.4 Hexin Pharmaceutical Revenue in Targeted Radionuclide Drug Business (2020-2025)
11.24.5 Hexin Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
POINT Biopharma
Telix
ITM
Bayer
Novartis
Lantheus
Curium Pharma
Fusion Pharmaceuticals
RadioMedix
Ionetix
Clarity Pharmaceuticals
RayzeBio
AmbioPharm
Bracco Imaging
Navidea
China Isotope & Radiation Corporation
Yantai Dongcheng
Grand Pharma
Hengrui Medicine
Yunnan Baiyao Group
SmartNuclide Biopharma
Sinotau
Hexin Pharmaceutical
Convergent Therapeutics
List of Tables
 Table 1. Global Targeted Radionuclide Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Medicine
 Table 3. Key Players of Inhibitor
 Table 4. Global Targeted Radionuclide Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Targeted Radionuclide Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Targeted Radionuclide Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Targeted Radionuclide Drug Market Share by Region (2020-2025)
 Table 8. Global Targeted Radionuclide Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Targeted Radionuclide Drug Market Share by Region (2026-2031)
 Table 10. Targeted Radionuclide Drug Market Trends
 Table 11. Targeted Radionuclide Drug Market Drivers
 Table 12. Targeted Radionuclide Drug Market Challenges
 Table 13. Targeted Radionuclide Drug Market Restraints
 Table 14. Global Targeted Radionuclide Drug Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Targeted Radionuclide Drug Market Share by Players (2020-2025)
 Table 16. Global Top Targeted Radionuclide Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Radionuclide Drug as of 2024)
 Table 17. Ranking of Global Top Targeted Radionuclide Drug Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Targeted Radionuclide Drug Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Targeted Radionuclide Drug, Headquarters and Area Served
 Table 20. Global Key Players of Targeted Radionuclide Drug, Product and Application
 Table 21. Global Key Players of Targeted Radionuclide Drug, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Targeted Radionuclide Drug Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Targeted Radionuclide Drug Revenue Market Share by Type (2020-2025)
 Table 25. Global Targeted Radionuclide Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Targeted Radionuclide Drug Revenue Market Share by Type (2026-2031)
 Table 27. Global Targeted Radionuclide Drug Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Targeted Radionuclide Drug Revenue Market Share by Application (2020-2025)
 Table 29. Global Targeted Radionuclide Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Targeted Radionuclide Drug Revenue Market Share by Application (2026-2031)
 Table 31. North America Targeted Radionuclide Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Targeted Radionuclide Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Targeted Radionuclide Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Targeted Radionuclide Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Targeted Radionuclide Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Targeted Radionuclide Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Targeted Radionuclide Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Targeted Radionuclide Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Targeted Radionuclide Drug Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Targeted Radionuclide Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Targeted Radionuclide Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Targeted Radionuclide Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Targeted Radionuclide Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Targeted Radionuclide Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Targeted Radionuclide Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 46. POINT Biopharma Company Details
 Table 47. POINT Biopharma Business Overview
 Table 48. POINT Biopharma Targeted Radionuclide Drug Product
 Table 49. POINT Biopharma Revenue in Targeted Radionuclide Drug Business (2020-2025) & (US$ Million)
 Table 50. POINT Biopharma Recent Development
 Table 51. Telix Company Details
 Table 52. Telix Business Overview
 Table 53. Telix Targeted Radionuclide Drug Product
 Table 54. Telix Revenue in Targeted Radionuclide Drug Business (2020-2025) & (US$ Million)
 Table 55. Telix Recent Development
 Table 56. ITM AG Company Details
 Table 57. ITM AG Business Overview
 Table 58. ITM AG Targeted Radionuclide Drug Product
 Table 59. ITM AG Revenue in Targeted Radionuclide Drug Business (2020-2025) & (US$ Million)
 Table 60. ITM AG Recent Development
 Table 61. Bayer AG Company Details
 Table 62. Bayer AG Business Overview
 Table 63. Bayer AG Targeted Radionuclide Drug Product
 Table 64. Bayer AG Revenue in Targeted Radionuclide Drug Business (2020-2025) & (US$ Million)
 Table 65. Bayer AG Recent Development
 Table 66. Novartis Company Details
 Table 67. Novartis Business Overview
 Table 68. Novartis Targeted Radionuclide Drug Product
 Table 69. Novartis Revenue in Targeted Radionuclide Drug Business (2020-2025) & (US$ Million)
 Table 70. Novartis Recent Development
 Table 71. Lantheus Company Details
 Table 72. Lantheus Business Overview
 Table 73. Lantheus Targeted Radionuclide Drug Product
 Table 74. Lantheus Revenue in Targeted Radionuclide Drug Business (2020-2025) & (US$ Million)
 Table 75. Lantheus Recent Development
 Table 76. Curium Pharma Company Details
 Table 77. Curium Pharma Business Overview
 Table 78. Curium Pharma Targeted Radionuclide Drug Product
 Table 79. Curium Pharma Revenue in Targeted Radionuclide Drug Business (2020-2025) & (US$ Million)
 Table 80. Curium Pharma Recent Development
 Table 81. Fusion Pharmaceuticals Company Details
 Table 82. Fusion Pharmaceuticals Business Overview
 Table 83. Fusion Pharmaceuticals Targeted Radionuclide Drug Product
 Table 84. Fusion Pharmaceuticals Revenue in Targeted Radionuclide Drug Business (2020-2025) & (US$ Million)
 Table 85. Fusion Pharmaceuticals Recent Development
 Table 86. RadioMedix, Inc. Company Details
 Table 87. RadioMedix, Inc. Business Overview
 Table 88. RadioMedix, Inc. Targeted Radionuclide Drug Product
 Table 89. RadioMedix, Inc. Revenue in Targeted Radionuclide Drug Business (2020-2025) & (US$ Million)
 Table 90. RadioMedix, Inc. Recent Development
 Table 91. Convergent Therapeutics Company Details
 Table 92. Convergent Therapeutics Business Overview
 Table 93. Convergent Therapeutics Targeted Radionuclide Drug Product
 Table 94. Convergent Therapeutics Revenue in Targeted Radionuclide Drug Business (2020-2025) & (US$ Million)
 Table 95. Convergent Therapeutics Recent Development
 Table 96. IONETIX Company Details
 Table 97. IONETIX Business Overview
 Table 98. IONETIX Targeted Radionuclide Drug Product
 Table 99. IONETIX Revenue in Targeted Radionuclide Drug Business (2020-2025) & (US$ Million)
 Table 100. IONETIX Recent Development
 Table 101. Clarity Pharmaceuticals Company Details
 Table 102. Clarity Pharmaceuticals Business Overview
 Table 103. Clarity Pharmaceuticals Targeted Radionuclide Drug Product
 Table 104. Clarity Pharmaceuticals Revenue in Targeted Radionuclide Drug Business (2020-2025) & (US$ Million)
 Table 105. Clarity Pharmaceuticals Recent Development
 Table 106. RayzeBio, Inc Company Details
 Table 107. RayzeBio, Inc Business Overview
 Table 108. RayzeBio, Inc Targeted Radionuclide Drug Product
 Table 109. RayzeBio, Inc Revenue in Targeted Radionuclide Drug Business (2020-2025) & (US$ Million)
 Table 110. RayzeBio, Inc Recent Development
 Table 111. AmbioPharm Company Details
 Table 112. AmbioPharm Business Overview
 Table 113. AmbioPharm Targeted Radionuclide Drug Product
 Table 114. AmbioPharm Revenue in Targeted Radionuclide Drug Business (2020-2025) & (US$ Million)
 Table 115. AmbioPharm Recent Development
 Table 116. Bracco Imaging Company Details
 Table 117. Bracco Imaging Business Overview
 Table 118. Bracco Imaging Targeted Radionuclide Drug Product
 Table 119. Bracco Imaging Revenue in Targeted Radionuclide Drug Business (2020-2025) & (US$ Million)
 Table 120. Bracco Imaging Recent Development
 Table 121. Navidea Company Details
 Table 122. Navidea Business Overview
 Table 123. Navidea Targeted Radionuclide Drug Product
 Table 124. Navidea Revenue in Targeted Radionuclide Drug Business (2020-2025) & (US$ Million)
 Table 125. Navidea Recent Development
 Table 126. China Isotope & Radiation Corporation Company Details
 Table 127. China Isotope & Radiation Corporation Business Overview
 Table 128. China Isotope & Radiation Corporation Targeted Radionuclide Drug Product
 Table 129. China Isotope & Radiation Corporation Revenue in Targeted Radionuclide Drug Business (2020-2025) & (US$ Million)
 Table 130. China Isotope & Radiation Corporation Recent Development
 Table 131. Yantai Dongcheng Company Details
 Table 132. Yantai Dongcheng Business Overview
 Table 133. Yantai Dongcheng Targeted Radionuclide Drug Product
 Table 134. Yantai Dongcheng Revenue in Targeted Radionuclide Drug Business (2020-2025) & (US$ Million)
 Table 135. Yantai Dongcheng Recent Development
 Table 136. Grand Pharma Company Details
 Table 137. Grand Pharma Business Overview
 Table 138. Grand Pharma Targeted Radionuclide Drug Product
 Table 139. Grand Pharma Revenue in Targeted Radionuclide Drug Business (2020-2025) & (US$ Million)
 Table 140. Grand Pharma Recent Development
 Table 141. Hengrui Medicine Company Details
 Table 142. Hengrui Medicine Business Overview
 Table 143. Hengrui Medicine Targeted Radionuclide Drug Product
 Table 144. Hengrui Medicine Revenue in Targeted Radionuclide Drug Business (2020-2025) & (US$ Million)
 Table 145. Hengrui Medicine Recent Development
 Table 146. Yunnan Baiyao Group Company Details
 Table 147. Yunnan Baiyao Group Business Overview
 Table 148. Yunnan Baiyao Group Targeted Radionuclide Drug Product
 Table 149. Yunnan Baiyao Group Revenue in Targeted Radionuclide Drug Business (2020-2025) & (US$ Million)
 Table 150. Yunnan Baiyao Group Recent Development
 Table 151. SmartNuclide Biopharma Company Details
 Table 152. SmartNuclide Biopharma Business Overview
 Table 153. SmartNuclide Biopharma Targeted Radionuclide Drug Product
 Table 154. SmartNuclide Biopharma Revenue in Targeted Radionuclide Drug Business (2020-2025) & (US$ Million)
 Table 155. SmartNuclide Biopharma Recent Development
 Table 156. Sinotau Company Details
 Table 157. Sinotau Business Overview
 Table 158. Sinotau Targeted Radionuclide Drug Product
 Table 159. Sinotau Revenue in Targeted Radionuclide Drug Business (2020-2025) & (US$ Million)
 Table 160. Sinotau Recent Development
 Table 161. Hexin Pharmaceutical Company Details
 Table 162. Hexin Pharmaceutical Business Overview
 Table 163. Hexin Pharmaceutical Targeted Radionuclide Drug Product
 Table 164. Hexin Pharmaceutical Revenue in Targeted Radionuclide Drug Business (2020-2025) & (US$ Million)
 Table 165. Hexin Pharmaceutical Recent Development
 Table 166. Research Programs/Design for This Report
 Table 167. Key Data Information from Secondary Sources
 Table 168. Key Data Information from Primary Sources
 Table 169. Authors List of This Report


List of Figures
 Figure 1. Targeted Radionuclide Drug Picture
 Figure 2. Global Targeted Radionuclide Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Targeted Radionuclide Drug Market Share by Type: 2024 VS 2031
 Figure 4. Medicine Features
 Figure 5. Inhibitor Features
 Figure 6. Global Targeted Radionuclide Drug Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Targeted Radionuclide Drug Market Share by Application: 2024 VS 2031
 Figure 8. Tumors Case Studies
 Figure 9. Thyroid Case Studies
 Figure 10. Others Case Studies
 Figure 11. Targeted Radionuclide Drug Report Years Considered
 Figure 12. Global Targeted Radionuclide Drug Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Targeted Radionuclide Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Targeted Radionuclide Drug Market Share by Region: 2024 VS 2031
 Figure 15. Global Targeted Radionuclide Drug Market Share by Players in 2024
 Figure 16. Global Top Targeted Radionuclide Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Radionuclide Drug as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Targeted Radionuclide Drug Revenue in 2024
 Figure 18. North America Targeted Radionuclide Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Targeted Radionuclide Drug Market Share by Country (2020-2031)
 Figure 20. United States Targeted Radionuclide Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Targeted Radionuclide Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Targeted Radionuclide Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Targeted Radionuclide Drug Market Share by Country (2020-2031)
 Figure 24. Germany Targeted Radionuclide Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Targeted Radionuclide Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Targeted Radionuclide Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Targeted Radionuclide Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Targeted Radionuclide Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Targeted Radionuclide Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Targeted Radionuclide Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Targeted Radionuclide Drug Market Share by Region (2020-2031)
 Figure 32. China Targeted Radionuclide Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Targeted Radionuclide Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Targeted Radionuclide Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Targeted Radionuclide Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Targeted Radionuclide Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Targeted Radionuclide Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Targeted Radionuclide Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Targeted Radionuclide Drug Market Share by Country (2020-2031)
 Figure 40. Mexico Targeted Radionuclide Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Targeted Radionuclide Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Targeted Radionuclide Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Targeted Radionuclide Drug Market Share by Country (2020-2031)
 Figure 44. Turkey Targeted Radionuclide Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Targeted Radionuclide Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Targeted Radionuclide Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. POINT Biopharma Revenue Growth Rate in Targeted Radionuclide Drug Business (2020-2025)
 Figure 48. Telix Revenue Growth Rate in Targeted Radionuclide Drug Business (2020-2025)
 Figure 49. ITM AG Revenue Growth Rate in Targeted Radionuclide Drug Business (2020-2025)
 Figure 50. Bayer AG Revenue Growth Rate in Targeted Radionuclide Drug Business (2020-2025)
 Figure 51. Novartis Revenue Growth Rate in Targeted Radionuclide Drug Business (2020-2025)
 Figure 52. Lantheus Revenue Growth Rate in Targeted Radionuclide Drug Business (2020-2025)
 Figure 53. Curium Pharma Revenue Growth Rate in Targeted Radionuclide Drug Business (2020-2025)
 Figure 54. Fusion Pharmaceuticals Revenue Growth Rate in Targeted Radionuclide Drug Business (2020-2025)
 Figure 55. RadioMedix, Inc. Revenue Growth Rate in Targeted Radionuclide Drug Business (2020-2025)
 Figure 56. Convergent Therapeutics Revenue Growth Rate in Targeted Radionuclide Drug Business (2020-2025)
 Figure 57. IONETIX Revenue Growth Rate in Targeted Radionuclide Drug Business (2020-2025)
 Figure 58. Clarity Pharmaceuticals Revenue Growth Rate in Targeted Radionuclide Drug Business (2020-2025)
 Figure 59. RayzeBio, Inc Revenue Growth Rate in Targeted Radionuclide Drug Business (2020-2025)
 Figure 60. AmbioPharm Revenue Growth Rate in Targeted Radionuclide Drug Business (2020-2025)
 Figure 61. Bracco Imaging Revenue Growth Rate in Targeted Radionuclide Drug Business (2020-2025)
 Figure 62. Navidea Revenue Growth Rate in Targeted Radionuclide Drug Business (2020-2025)
 Figure 63. China Isotope & Radiation Corporation Revenue Growth Rate in Targeted Radionuclide Drug Business (2020-2025)
 Figure 64. Yantai Dongcheng Revenue Growth Rate in Targeted Radionuclide Drug Business (2020-2025)
 Figure 65. Grand Pharma Revenue Growth Rate in Targeted Radionuclide Drug Business (2020-2025)
 Figure 66. Hengrui Medicine Revenue Growth Rate in Targeted Radionuclide Drug Business (2020-2025)
 Figure 67. Yunnan Baiyao Group Revenue Growth Rate in Targeted Radionuclide Drug Business (2020-2025)
 Figure 68. SmartNuclide Biopharma Revenue Growth Rate in Targeted Radionuclide Drug Business (2020-2025)
 Figure 69. Sinotau Revenue Growth Rate in Targeted Radionuclide Drug Business (2020-2025)
 Figure 70. Hexin Pharmaceutical Revenue Growth Rate in Targeted Radionuclide Drug Business (2020-2025)
 Figure 71. Bottom-up and Top-down Approaches for This Report
 Figure 72. Data Triangulation
 Figure 73. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Radioisotope Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Radiopharmaceutical for Nuclear Medicine Market Research Report 2024
Radionuclide Drug Conjugates RDC Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nuclear Radiopharmaceutical Market Insights Forecast to 2030
Global Radioactive Isotopes Market Research Report 2025
Radiology Drug Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nuclear Medicine Imaging Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oncology Radiopharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Radioactive Medical Isotopes Market Research Report 2024
Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Research Report 2024
Global Radioisotopes in Industry Market Research Report 2025
Radiotheranostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Targeted Delivery Drugs Market Research Report 2024
Global Radioligand Therapy Market Research Report 2025
Global Radioactive Tracers Market Research Report 2024
Nuclear Medicine Science Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Innovative Small Molecule Targeted Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Industrial Radioisotope Market Research Report 2025
Global Pet Cancer Targeted Drug Market Research Report 2024
Global Nuclear Medicine Solutions Market Research Report 2024

RELATED REPORTS

Global Cephalosporin APIs and Cephalosporin Intermediates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19G16926
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global ELISA Immunoassay Plates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7Z17064
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ready-to-Use ELISA Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20P20045
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Moxidectin Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3Z19977
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions